IP Library Granted Patent US 7,655,243
Granted Patent B2
US 7,655,243 · App. 11/750,963 · Granted Feb 2, 2010

Methods and systems for toxin delivery to the nasal cavity

Assignee: The Foundry, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,243
App. No.
11/750,963
Granted
Feb 2, 2010
Kind
B2
Abstract

Methods and systems for delivering toxin and toxin fragments to a patient's nasal cavity provide for both release of the toxin and delivery of energy which selectively porates target cells to enhance uptake of the toxin. The use of energy-mediated delivery is particularly advantageous with light chain fragment toxins which lack cell binding capacity.

Claims (37)

1. A method for delivering toxins to target cells in a nasal membrane of a patient, said method comprising:

introducing a toxin to a region proximate the target cells, said toxin comprising a light chain fragment of a neurotoxin and being substantially free of heavy chain fragments of the neurotoxin; and

applying energy to the target cells to enhance delivery of the toxin to the cells.

2. A method as in claim 1 , wherein the region comprises at least one paranasal sinus, a main nasal passage or a nasal turbinate.

3. A method as in claim 1 , wherein the region comprises substantially the entire nasal cavity.

4. A method as in claim 1 , wherein the region comprises the nasopharynx.

5. A method as in claim 1 , wherein the target cells comprise epithelial or goblet cells.

6. A method as in claim 1 , wherein the energy is selectively applied to target cells within the region where the toxin has been introduced.

7. A method as in claim 1 , wherein the energy is applied non-selectively within the region where the toxin has been introduced.

8. A method as in claim 1 , wherein the patient suffers from or is at risk of suffering from rhinorreah.

9. A method as in claim 1 , wherein the patient suffers from or is at risk of suffering from sinus headaches.

10. A method as in claim 1 , wherein the patient suffers from or is at risk of suffering from migraine headaches.

11. A method as in claim 1 , wherein the neurotoxin consists of botulinum toxin.

12. A method as in claim 11 , wherein the light chain fragment is derived from at least one of botulinum toxins A, B, C, D, E, F, and G.

13. A method as in claim 1 , wherein the energy applied to the targeted region is an electric pulse.

14. A method as in claim 13 , wherein the electric pulse is applied from between 1V to 500V.

15. A method as in claim 13 , wherein the electric pulse is an RF signal.

16. A method of claim 13 , wherein the electric pulse is pulsed for durations between 5 microseconds to 100 milliseconds.

17. A method as in claim 13 , wherein the electric pulse is produced by a DC power source.

18. A method as in claim 13 , wherein the electric pulse is produced by an AC power source.

19. A method as in claim 1 , wherein the energy applied to the target region is ultrasonic.

20. A method as in claim 1 , wherein the energy applied to the targeted region is an x-ray beam.

21. A method as in claim 1 , wherein the energy applied to the targeted region is focused ultrasound.

22. A method as in claim 1 , wherein the energy applied to the targeted region is microwave.

23. A method as in claim 1 , wherein the toxin is introduced to the target region through a catheter.

24. A method as in claim 23 , wherein the toxin is introduced through a balloon on the catheter.

25. A method as in claim 24 , wherein the balloon is porous and the toxin is introduced through the balloon.

26. A method as in claim 23 , wherein the toxin is introduced through a needle on the catheter.

27. A method as in claim 23 , wherein the toxin is aerosolized from the catheter.

28. A method as in claim 23 , wherein energy is applied from a source on the catheter.

29. A method as in claim 28 , wherein acoustic energy is applied from a transducer on the catheter.

30. A method as in claim 28 , wherein electrical energy is applied from an electrode on the catheter.

31. A method as in claim 1 , wherein the energy is delivered from a source external to the patient.

32. A method as in claim 31 , wherein the source is an acoustic energy transducer.

33. A method as in claim 32 , wherein the acoustic energy transducer is a focused ultrasound transducer.

34. A method as in claim 1 , wherein applying energy to the target cells further comprises applying energy to the target cells under conditions which cause poration of the cell membranes.

35. A method as in claim 28 , wherein microwave energy is applied from an antenna on the catheter.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2009
From: THE FOUNDRY, INC.
To: THE FOUNDRY, LLC
Reel/Frame 022520/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2007
From: DEEM, MARK E.; GIFFORD, HANSON
To: THE FOUNDRY, INC.
Reel/Frame 019926/0861 →
Continuity (4)
Continuation In Part 1145909000 · Jul 21, 2006
Provisional Application 6074777100 · May 19, 2006
Provisional Application 6070207700 · Jul 22, 2005
Related Publication 20080021369A1 · Jan 24, 2008